-
1.Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands 失效
标题翻译: 取代的二氢[1,4]恶嗪并[2,3,4-hi]吲唑衍生物,为5-羟色胺-6配体公开(公告)号:US07414051B2
公开(公告)日:2008-08-19
申请号:US11786315
申请日:2007-04-11
申请人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Cristina Grosanu , Albert Jean Robichaud
发明人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Cristina Grosanu , Albert Jean Robichaud
IPC分类号: C07D498/04 , A61K31/5365
CPC分类号: C07D498/06
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
2.Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands 失效
标题翻译: 二氢[1,4]恶嗪并[2,3,4-hi]吲唑衍生物作为5-羟基色胺-6配体公开(公告)号:US20070244105A1
公开(公告)日:2007-10-18
申请号:US11786314
申请日:2007-04-11
申请人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
发明人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
IPC分类号: A61K31/538 , C07D491/04
CPC分类号: C07D491/06
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
3.SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 审中-公开
标题翻译: 取代的二氢[1,4]氧杂蒽并[2,3,4-hi]吲哚衍生物作为5-羟基木聚糖-6配体公开(公告)号:US20080280893A1
公开(公告)日:2008-11-13
申请号:US12172542
申请日:2008-07-14
申请人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Cristina Grosanu , Albert Jean Robichaud
发明人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Cristina Grosanu , Albert Jean Robichaud
IPC分类号: A61K31/5383 , A61P25/28
CPC分类号: C07D498/06
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
4.Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands 失效
标题翻译: 氮茚基-3-磺基吲唑衍生物作为5-羟基色胺-6配体公开(公告)号:US07790751B2
公开(公告)日:2010-09-07
申请号:US11504243
申请日:2006-08-14
申请人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Kevin Liu , Geraldine Ruth McFarlane , Cristina Grosanu , Jennifer Rebecca Lo , Albert Jean Robichaud
发明人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Kevin Liu , Geraldine Ruth McFarlane , Cristina Grosanu , Jennifer Rebecca Lo , Albert Jean Robichaud
IPC分类号: A61K31/454 , C07D403/02
CPC分类号: C07D231/56 , C07D401/12 , C07D403/12
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
5.DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 审中-公开
标题翻译: 二氢[1,4] OXAZINO [2,3,4-hi]吲哚衍生物作为5-羟基木聚糖-6配体公开(公告)号:US20080280894A1
公开(公告)日:2008-11-13
申请号:US12173039
申请日:2008-07-15
申请人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
发明人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
IPC分类号: A61K31/5383 , A61P25/28
CPC分类号: C07D491/06
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
6.Dihydro[1,4]dioxino[2,3-e]indazole derivatives as 5-hydroxytryptamine-6 ligands 审中-公开
标题翻译: 二氢[1,4]二氧杂环己烯并[2,3-e]吲唑衍生物,为5-羟色胺-6配体公开(公告)号:US20070244179A1
公开(公告)日:2007-10-18
申请号:US11786316
申请日:2007-04-11
申请人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
发明人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
IPC分类号: A61K31/4162 , C07D491/02
CPC分类号: C07D491/056 , C07D491/04
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
7.Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands 有权
标题翻译: 取代的3-磺基吲唑衍生物作为5-羟色胺-6配体公开(公告)号:US07723329B2
公开(公告)日:2010-05-25
申请号:US11504350
申请日:2006-08-14
申请人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Kevin Liu , Robert Emmett McDevitt , Geraldine Ruth McFarlane , Cristina Grosanu , Jennifer Rebecca Lo , Yanfang Li , Albert Jean Robichaud , Ronald Charles Bernotas
发明人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Kevin Liu , Robert Emmett McDevitt , Geraldine Ruth McFarlane , Cristina Grosanu , Jennifer Rebecca Lo , Yanfang Li , Albert Jean Robichaud , Ronald Charles Bernotas
IPC分类号: A61K31/5377 , A61K31/496 , A61K31/416 , C07D413/02 , C07D231/56
CPC分类号: C07D231/56 , C07D401/12 , C07D403/06 , C07D403/12 , C07D413/12
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
8.Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands and use thereof in the treatment of attention deficit disorders 失效
标题翻译: 二氢[1,4]恶嗪并[2,3,4-hi]吲唑衍生物作为5-羟色胺-6配体及其在治疗注意力缺陷障碍中的应用公开(公告)号:US07429582B2
公开(公告)日:2008-09-30
申请号:US11786314
申请日:2007-04-11
申请人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
发明人: Alexander Alexei Greenfield , Cristina Grosanu , Hassan Mahmoud Elokdah , Albert Jean Robichaud
IPC分类号: C07D498/04 , A61K31/5365
CPC分类号: C07D491/06
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途
-
9.Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands 失效
标题翻译: 取代的二氢[1,4]恶嗪并[2,3,4-hi]吲唑衍生物,为5-羟色胺-6配体公开(公告)号:US20070244106A1
公开(公告)日:2007-10-18
申请号:US11786315
申请日:2007-04-11
申请人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Cristina Grosanu , Albert Jean Robichaud
发明人: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Cristina Grosanu , Albert Jean Robichaud
IPC分类号: A61K31/5383 , C07D491/04
CPC分类号: C07D498/06
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
10.Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands 失效
标题翻译: 亚乙烯基-3-磺基吲唑衍生物作为5-羟基色胺-6配体公开(公告)号:US20070054896A1
公开(公告)日:2007-03-08
申请号:US11504243
申请日:2006-08-14
申请人: Hassan Elokdah , Alexander Greenfield , Kevin Liu , Geraldine McFarlane , Cristina Grosanu , Jennifer Lo , Albert Robichaud
发明人: Hassan Elokdah , Alexander Greenfield , Kevin Liu , Geraldine McFarlane , Cristina Grosanu , Jennifer Lo , Albert Robichaud
IPC分类号: A61K31/55 , A61K31/454 , A61K31/416 , C07D403/02
CPC分类号: C07D231/56 , C07D401/12 , C07D403/12
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。
-
-
-
-
-
-
-
-
-